2013
DOI: 10.1016/j.bios.2013.01.016
|View full text |Cite
|
Sign up to set email alerts
|

Integration of gold nanoparticles in PDMS microfluidics for lab-on-a-chip plasmonic biosensing of growth hormones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
82
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 132 publications
(83 citation statements)
references
References 37 publications
1
82
0
Order By: Relevance
“…An alternative way to prepare AuNPs was proposed by SadAbadi et al [93] using PDMS microchannels; and afterwards, the device was used as a sensitive and low-cost localized surface plasmon resonance (SPR)-based biosensor for the detection of polypeptides. The biosensing experiment was based on the detection of antigen-antibody interaction of bovine growth hormones through the measurement of localized SPR spectra of the samples.…”
Section: Gold Nanoparticlesmentioning
confidence: 99%
“…An alternative way to prepare AuNPs was proposed by SadAbadi et al [93] using PDMS microchannels; and afterwards, the device was used as a sensitive and low-cost localized surface plasmon resonance (SPR)-based biosensor for the detection of polypeptides. The biosensing experiment was based on the detection of antigen-antibody interaction of bovine growth hormones through the measurement of localized SPR spectra of the samples.…”
Section: Gold Nanoparticlesmentioning
confidence: 99%
“…It is estimated that the global biochips market will increase from $3.3 billion in year 2012 to $14.4 billion by year 2018, with a compound annual growth rate of 30 % [360]. Due to nanoparticles' unique characteristics, they are often used in lab-on-achip products for various functions, such as property improver, catalyst, sensing, imaging, and as a carrier [145,258,348,371,417]. For example, in a microfluidic-based chip for early detection of HIV and syphilis, Au nanoparticles are used as carriers and labelers for antibodies and also a substrate for Ag reduction, as shown in Fig.…”
Section: Biomedicinementioning
confidence: 99%
“…As can be seen, synthesis of metal NPs starts with a metal containing salt solution and a reducing agent, although sometimes the reducing agent is not needed. 22,23 Thereafter, usually ligands or surfactants, the so-called capping agents, are used to control the shape and size of the structures. The type and mode of mixing of these ligands have a great influence on the final shape and composition of the NPs.…”
Section: Introductionmentioning
confidence: 99%